These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3949927)

  • 1. Separation of spironolactone and its biologically active sulfur-containing metabolites by high-performance liquid chromatography.
    Sherry JH; O'Donnell JP; Colby HD
    J Chromatogr; 1986 Jan; 374(1):183-90. PubMed ID: 3949927
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples.
    Sandall JM; Millership JS; Collier PS; McElnay JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 839(1-2):36-44. PubMed ID: 16510319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous separation and rapid determination of spironolactone and its metabolite canrenone in different pharmaceutical formulations and urinary matrices by capillary zone electrophoresis.
    Li L; Huang Y; Zhao W; Zhang G; Zhang H; Chen A
    J Sep Sci; 2016 Jul; 39(14):2869-75. PubMed ID: 27257119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone metabolism: steady-state serum levels of the sulfur-containing metabolites.
    Gardiner P; Schrode K; Quinlan D; Martin BK; Boreham DR; Rogers MS; Stubbs K; Smith M; Karim A
    J Clin Pharmacol; 1989 Apr; 29(4):342-7. PubMed ID: 2723123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
    Los LE; Coddington AB; Ramjit HG; Colby HD
    Drug Metab Dispos; 1993; 21(6):1086-90. PubMed ID: 7905388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography.
    Overdiek JW; Hermens WA; Merkus FW
    J Chromatogr; 1985 Jun; 341(2):279-85. PubMed ID: 4030980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of canrenone, the major metabolite of spironolactone, in plasma and urine by high-performance liquid chromatography.
    Krause W; Karras J; Jakobs U
    J Chromatogr; 1983 Oct; 277():191-9. PubMed ID: 6643605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS.
    Dong H; Xu F; Zhang Z; Tian Y; Chen Y
    J Mass Spectrom; 2006 Apr; 41(4):477-86. PubMed ID: 16541392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum.
    Kaukonen AM; Vuorela P; Vuorela H; Mannermaa JP
    J Chromatogr A; 1998 Feb; 797(1-2):271-81. PubMed ID: 9542120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of a sulfur-containing metabolite of spironolactone from human urine.
    Koch K; Senn M; Steingross W
    Steroids; 1976 Oct; 28(4):467-80. PubMed ID: 1006719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of microsomal spironolactone metabolism by reduced glutathione.
    Colby HD; LaCagnin LB; Los LE
    Pharmacology; 1996 Jan; 52(1):30-4. PubMed ID: 8966200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on the bioequivalence of 2 oral preparations containing spironolactone and furosemide.
    Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):231-8. PubMed ID: 9587051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of canrenone, a major metabolite of spironolactone, in body fluids.
    Neurath GB; Ambrosius D
    J Chromatogr; 1979 Jun; 163(2):230-5. PubMed ID: 541378
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs.
    Los LE; Colby HD
    Pharmacology; 1994 Feb; 48(2):86-92. PubMed ID: 8134406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies and bioavailability of bendroflumethiazide in combination with spironolactone].
    Vergin H; Nuss U; Strobel K
    Arzneimittelforschung; 1986 Mar; 36(3):490-5. PubMed ID: 3707669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical issues in HPLC/MS/MS simultaneous assay of furosemide, spironolactone and canrenone in human plasma samples.
    Sora DI; Udrescu S; Albu F; David V; Medvedovici A
    J Pharm Biomed Anal; 2010 Sep; 52(5):734-40. PubMed ID: 20307949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples.
    Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):29-35. PubMed ID: 30165207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.
    Karim A; Hribar J; Aksamit W; Doherty M; Chinn LJ
    Drug Metab Dispos; 1975; 3(6):467-78. PubMed ID: 1221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformations of the cardiovascular drugs mexrenone and canrenone.
    Preisig CL; Laakso JA; Mocek UM; Wang PT; Baez J; Byng G
    J Nat Prod; 2003 Mar; 66(3):350-6. PubMed ID: 12662091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
    Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
    J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.